ALT Stock | | | USD 8.25 0.07 0.86% |
This module uses fundamental data of Altimmune to approximate its Piotroski F score. Altimmune F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Altimmune. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Altimmune financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out
Altimmune Altman Z Score,
Altimmune Correlation,
Altimmune Valuation, as well as analyze
Altimmune Alpha and Beta and
Altimmune Hype Analysis.
For more information on how to buy Altimmune Stock please use our
How to Invest in Altimmune guide.
Long Term Debt Total is likely to gain to about 2
M in 2024, despite the fact that
Net Debt is likely to grow to (127.7
M). At this time, Altimmune's
Research And Ddevelopement To Revenue is comparatively stable compared to the past year.
Days Payables Outstanding is likely to gain to 2,104 in 2024, despite the fact that
Free Cash Flow Yield is likely to grow to
(0.12).
At this time, it appears that Altimmune's Piotroski F Score is Unavailable. Although some professional money managers and academia have recently criticized
Piotroski F-Score model, we still consider it an effective method of
predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
4.0
Piotroski F Score - Unavailable
| Current Return On Assets | Negative | Focus |
| Change in Return on Assets | Decreased | Focus |
| Cash Flow Return on Assets | Negative | Focus |
| Current Quality of Earnings (accrual) | Improving | Focus |
| Asset Turnover Growth | Decrease | Focus |
| Current Ratio Change | Increase | Focus |
| Long Term Debt Over Assets Change | Lower Leverage | Focus |
| Change In Outstending Shares | Increase | Focus |
| Change in Gross Margin | Increase | Focus |
Altimmune Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to Altimmune is to make sure Altimmune is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Altimmune's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Altimmune's financial numbers are properly reported.
Altimmune F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical
financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Altimmune's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Altimmune in a much-optimized way.
Click cells to compare fundamentals
About Altimmune Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled
Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.
Altimmune Current Valuation Drivers
We derive many important indicators used in calculating different scores of Altimmune from analyzing Altimmune's financial statements. These drivers represent accounts that assess Altimmune's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Altimmune's important valuation drivers and their relationship over time.
| | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) |
Market Cap | | 24.8M | 289.2M | 378.2M | 771.9M | 599.0M | 629.0M |
Enterprise Value | | 17.6M | 175.1M | 189.4M | 662.0M | 464.6M | 487.8M |
Altimmune ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Altimmune's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Altimmune's managers, analysts, and investors.
About Altimmune Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Altimmune's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Altimmune using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at
the intrinsic value of Altimmune based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing
financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our
fundamental analysis page.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Altimmune Stock Analysis
When running Altimmune's price analysis, check to
measure Altimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Altimmune is operating at the current time. Most of Altimmune's value examination focuses on studying past and present price action to
predict the probability of Altimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Altimmune's price. Additionally, you may evaluate how the addition of Altimmune to your portfolios can decrease your overall portfolio volatility.